In its 13F for Q2 2026 (holdings as of June 30, 2026, filed July 23, 2026), Lunate Capital Ltd reported 10 stock positions worth $196.0 million . Its top holding was Sailpoint (SAIL) at 22.4% of the portfolio, followed by Birkenstock (BIRK, 22.2% ) and Lineage (LINE, 13.2% ). Compared with Q1 2026, it opened 6 new positions and sold out of 1. The biggest buy was a new position in Birkenstock (BIRK) and the biggest sale an exit from Revolution Medicines (RVMD).
Location AL MARYAH ISLAND, ABU DHABI, C0
CIK 0002056786
Portfolio Value $196.0M (Q2 2026) Holdings 10 stocks · $196.0M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2026 SAIL Sailpoint Inc. 22.41% 3,000,000 $43.9M No change BIRK Birkenstock Holding PLC 22.17% 1,010,000 $43.5M New LINE Lineage Inc. 13.24% 600,000 $25.9M No change BXSL Blackstone Secured Lending F 12.11% 1,000,818 $23.7M New GSBD Goldman Sachs BDC Inc. 10.60% 2,192,392 $20.8M New MSDL Morgan Stanley Direct Lendin 8.51% 1,103,814 $16.7M New OBDC Blue Owl Capital Corp. 6.66% 1,200,244 $13.0M New NAVN Navan Inc. Class A 2.33% 200,000 $4.6M No change NMRA Neumora Therapeutics Inc. 1.84% 2,124,143 $3.6M No change FIG Figma Inc. Class A 0.12% 13,290 $240K New
Portfolio Sells Q1 2026 → Q2 2026 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025
Stock Change vs Q1 2026 % Of Portfolio Change To Portfolio ▲ RVMD Revolution Medicines Inc. Sold out 0.00% −44.66
Portfolio Buys Q1 2026 → Q2 2026 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025
Stock Change vs Q1 2026 % Of Portfolio Change To Portfolio ▼ BIRK Birkenstock Holding PLC New 22.17% +22.17 BXSL Blackstone Secured Lending F New 12.11% +12.11 GSBD Goldman Sachs BDC Inc. New 10.60% +10.60 MSDL Morgan Stanley Direct Lendin New 8.51% +8.51 OBDC Blue Owl Capital Corp. New 6.66% +6.66 FIG Figma Inc. Class A New 0.12% +0.12
Notes & Other Activity Q1 2026 → Q2 2026 Security Class Change vs Q1 2026 Shares / Principal Value ▼ RVMDW Revolution Medicines Inc.-28 *W EXP 12/17/202 Sold out 450,000 $806Kbefore exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 10 $196.0M SAIL, BIRK, LINE, BXSL, GSBD Q1 2026 5 $119.6M RVMD, SAIL, LINE, NMRA, NAVN Q4 2025 5 $263.8M RVMD, SAIL, LINE, NMRA, NAVN Q3 2025 Amended 5 $220.6M RVMD, SAIL, FIGR, LINE, NMRA Q2 2025 5 $178.0M RVMD, SAIL, LINE, NMRA, IOT Q1 2025 4 $171.2M RVMD, SAIL, LINE, NMRA